Stem Cells, Vol 11, 112-119, Copyright © 1993 by AlphaMed Press

ORIGINAL ARTICLES

Analysis of the effects of tumor necrosis factor inhibitors on human hematopoiesis

A Ferrajoli, M Talpaz, R Kurzrock and Z Estrov
Department of Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston 77030.

Truncated soluble fragments of tumor necrosis factor (TNF) receptors have recently been isolated from human serum and urine. These shed forms of TNF receptors bind TNF-alpha and lymphotoxin and inhibit various effects of TNF in culture. In this study, we evaluated the role of these molecules in the hematopoietic system. TNF-alpha and lymphotoxin inhibited colony forming units granulocyte-macrophage (CFU- GM) and burst forming units-erythroid (BFU-E) in a dose-dependent fashion at concentrations ranging from 1 to 5,000 U/ml and 25 to 250 U/ml, respectively. TNF-alpha exerted a similar dose-dependent inhibitory effect on a CD34 enriched marrow cell population, suggesting that its effect is not mediated through CD34 accessory cells. Its suppressive effect was partially reversed by anti-TNF-alpha neutralizing antibodies, thus proving its specificity. Two shed forms of TNF receptors, TNF binding protein (TNF-bp) and TNF receptor fusion protein (TNFR-fc), had no significant effect on CFU-GM proliferation. Both molecules, however, significantly reversed the inhibitory effect of TNF-alpha (p < 0.015 and p < 0.03, respectively), whereas they had no effect on the lymphotoxin-induced CFU-GM growth inhibition. These results indicate that TNF-bp and TNFR-fc may modulate the inhibitory effects of TNF-alpha in the hematopoietic system.

This article has been cited by other articles:

				A. Ferrajoli, S. Faderl, Q. Van, P. Koch, D. Harris, Z. Liu, I. Hazan-Halevy, Y. Wang, H. M. Kantarjian, W. Priebe, et al. WP1066 Disrupts Janus Kinase-2 and Induces Caspase-Dependent Apoptosis in Acute Myelogenous Leukemia Cells Cancer Res., December 1, 2007; 67(23): 11291 - 11299. [Abstract] [Full Text] [PDF]

				S. Zhang, D. Wang, Z. Estrov, S. Raj, J. T. Willerson, and E. T.H. Yeh Both Cell Fusion and Transdifferentiation Account for the Transformation of Human Peripheral Blood CD34-Positive Cells Into Cardiomyocytes In Vivo Circulation, December 21, 2004; 110(25): 3803 - 3807. [Abstract] [Full Text] [PDF]

				A. Moldenhauer, J-H Shieh, A. Pruss, A. Salama, and M.A.S. Moore Tumor Necrosis Factor Alpha Enhances the Adenoviral Transduction of CD34+ Hematopoietic Progenitor Cells Stem Cells, May 1, 2004; 22(3): 283 - 291. [Abstract] [Full Text] [PDF]

				E. T.H. Yeh, S. Zhang, H. D. Wu, M. Korbling, J. T. Willerson, and Z. Estrov Transdifferentiation of Human Peripheral Blood CD34+-Enriched Cell Population Into Cardiomyocytes, Endothelial Cells, and Smooth Muscle Cells In Vivo Circulation, October 28, 2003; 108(17): 2070 - 2073. [Abstract] [Full Text] [PDF]

				A. Ferrajoli, M. J. Keating, T. Manshouri, F. J. Giles, A. Dey, Z. Estrov, C. A. Koller, R. Kurzrock, D. A. Thomas, S. Faderl, et al. The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia Blood, July 30, 2002; 100(4): 1215 - 1219. [Abstract] [Full Text] [PDF]

				D. Turbay, J. Lieberman, C. A. Alper, J. C. Delgado, D. Corzo, J. J. Yunis, and E. J. Yunis Tumor Necrosis Factor Constellation Polymorphism and Clozapine-Induced Agranulocytosis in Two Different Ethnic Groups Blood, June 1, 1997; 89(11): 4167 - 4174. [Abstract] [Full Text] [PDF]